• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of May 8, 2013

  • Print
  • Share
  • E-mail

Product Detail

Product Description Red Blood Cells Leukocytes Reduced
Recall Number B-0811-13
Classification Class III
Code Info W066509675798, W066509675749, W066509675728, W066509657517, W066509657518, W066509657532, W066509675814, W066509678095, W066509677794, W066509677801, W066509658117, W066509657524, W066509657540, W066509657556, W066509675781, W066509675730, W066509675741, W066509677810, W066509677815, W066509677433, W066509657515, W066509657558, W066509675892, W066S09675808, W066509675793 , W066509675802, W066509675804, W066509657532, W066509675692, W066509658672, W066509658119.
Product Distributed Qty 31 components
Reason For Recall Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed..

Event Detail

Event Id 54939
Product Type Biologics
Status Terminated
Recalling Firm Blood Bank of Alaska, Inc.
City Anchorage
State AK
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2010-01-07
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern New York, Alaska, Louisiana, and Texas.